论文信息 - Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol fo - 字舞流文

Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol fo

N. Reinmuth | F. Klauschen | C. Belka | P. Bartenstein | J. Neumann | A. Jung | M. Unterrainer | C. Eze | F. Manapov | A. Tufman | E. Nössner | C. Schulz | J. Taugner | L. Käsmann | J. Kumbrink | Thomas P.J. Hofer | S. Kenndoff | B. Flörsch | A. Nieto | C. Pelikan | P. Bartenstein